24.3 C
New York
Thursday, June 24, 2021

South Korea’s Celltrion to begin commercial production of COVID-19 antibody drug

Must read

Hundreds of unmarked graves found at Canadian indigenous school

World6 minutes ago (Jun 24, 2021 04:37PM ET) 2/2 (C) Reuters. The area of the Marieval Indian Residential School is seen in an undated map on...

Colombia union leader vows bigger antigovernment protests if demands not met

World7 minutes ago (Jun 24, 2021 04:36PM ET) (C) Reuters. FILE PHOTO: Demonstrators march during a protest demanding government action to tackle poverty, police violence...

Samuel L. Jackson, Danny Glover to receive honorary Oscars

World11 minutes ago (Jun 24, 2021 04:31PM ET) 2/2 (C) Reuters. FILE PHOTO: Actor Samuel L. Jackson poses for a portrait for Captain Marvel in Beverly...

Kansas City Fed survey shows manufacturing activity steady in June

Economic Indicators12 minutes ago (Jun 24, 2021 04:31PM ET) By Evan Sully (Reuters) - Manufacturing activity in several Midwestern and Rocky Mountain states ticked up...
imageCoronavirus9 minutes ago (Sep 08, 2020 05:35AM ET)

(C) Reuters. The logo of Celltrion is seen at company’s headquarters in Incheon

By Sangmi Cha

SEOUL (Reuters) – South Korea’s Celltrion Inc will begin commercial production of its experimental treatment for COVID-19 this month, it said on Tuesday, as it pushes ahead with clinical trials of the antibody drug.

The company said it planned to make a request soon to regulators for emergency use authorisation of the drug, but that it would start mass production – likely to amount to around 1 million doses – before receiving that approval.

The treatment became the country’s first COVID-19 antibody drug to be tested on humans after receiving regulatory approval in July for clinical trials.

“We have confirmed the safety of the antiviral antibody drug in the process of the local Phase I clinical trial,” Kwon Ki-sung, head of Celltrion’s R&D unit, told Reuters.

Celltrion completed a Phase I trial on 32 volunteers in the country and is enrolling an additional nine participants for another Phase I study before moving on to later stage trials, for which regulatory reviews are already underway.

The company is separately conducting overseas human trials of its treatment in the United Kingdom, which will be followed by global second and third stage trials in patients with mild and moderate symptoms.

Shares of Celltrion surged as much as 5.6% on Tuesday, while the broader KOSPI gained 0.7%.

Other companies developing potential COVID-19 treatments include Eli Lilly (NYSE:LLY) and Co, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and AbbVie (NYSE:ABBV).

South Korea’s Celltrion to begin commercial production of COVID-19 antibody drug

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

- Advertisement -

Latest article

Hundreds of unmarked graves found at Canadian indigenous school

World6 minutes ago (Jun 24, 2021 04:37PM ET) 2/2 (C) Reuters. The area of the Marieval Indian Residential School is seen in an undated map on...

Colombia union leader vows bigger antigovernment protests if demands not met

World7 minutes ago (Jun 24, 2021 04:36PM ET) (C) Reuters. FILE PHOTO: Demonstrators march during a protest demanding government action to tackle poverty, police violence...

Samuel L. Jackson, Danny Glover to receive honorary Oscars

World11 minutes ago (Jun 24, 2021 04:31PM ET) 2/2 (C) Reuters. FILE PHOTO: Actor Samuel L. Jackson poses for a portrait for Captain Marvel in Beverly...

Kansas City Fed survey shows manufacturing activity steady in June

Economic Indicators12 minutes ago (Jun 24, 2021 04:31PM ET) By Evan Sully (Reuters) - Manufacturing activity in several Midwestern and Rocky Mountain states ticked up...

BlackRock plans more employee support after review of complaints

Stock Markets12 minutes ago (Jun 24, 2021 04:31PM ET) (C) Reuters. The BlackRock logo is pictured outside their headquarters in the Manhattan borough of New...